Cancers, Vol. 11, Pages 64: Paroxetine Induces Apoptosis of Human Breast Cancer MCF-7 Cells through Ca2+-and p38 MAP Kinase-Dependent ROS Generation
In this study, we investigated whether and how SSRIs induce the death of human breast cancer MCF-7 cells. Of the antidepressants tested in this study (amitriptyline, bupropion, fluoxetine, paroxetine, and tianeptine), paroxetine most reduced the viability of MCF-7 cells in a time-and dose-dependent manner. The exposure of MCF-7 cells to paroxetine resulted in mitochondrion-mediated apoptosis, which is assessed by increase in the number of cells with sub-G1 DNA content, caspase-8/9 activation, poly (ADP-ribose) polymerase cleavage, and Bax/Bcl-2 ratio and a reduction in the mitochondrial membrane potential. Paroxetine increased a generation of reactive oxygen species (ROS), intracellular Ca2+ levels, and p38 MAPK activation. The paroxetine-induced apoptotic events were reduced by ROS scavengers and p38 MAPK inhibitor, and the paroxetine’s effect was dependent on extracellular Ca2+ level. Paroxetine also showed a synergistic effect on cell death induced by chemotherapeutic drugs in MCF-7 and MDA-MB-231 cells. Our results showed that paroxetine induced apoptosis of human breast cancer MCF-7 cells through extracellular Ca2+-and p38 MAPK-dependent ROS generation. These results suggest that paroxetine may serve as an anticancer adjuvant to current cancer therapies for breast cancer patients with or without depression.
Source: Cancers - Category: Cancer & Oncology Authors: Young-Woo Cho Eun-Jin Kim Marie Merci Nyiramana Eui-Jung Shin Hana Jin Ji Hyeon Ryu Kee Ryeon Kang Gyeong-Won Lee Hye Jung Kim Jaehee Han Dawon Kang Tags: Article Source Type: research
More News: Amitriptyline | Anxiety | Breast Cancer | Bupropion | Cancer | Cancer & Oncology | Cancer Therapy | Depression | Fluoxetine | Paroxetine | Paxil | Prozac | Study | Wellbutrin | Women